Transcription of ACTIVE PHARMACEUTICAL INGREDIENTS …
{{id}} {{{paragraph}}}
ACTIVE PHARMACEUTICAL INGREDIENTS COMMITTEE (APIC). eCTD HOW TO DO DOCUMENT. July 2014. APIC_eCTD How to Do Table of Content 1. CHAPTER 1: REGULATORY FRAMEWORK & NATIONAL Introduction: view of authorities in general & trend ..5. Requirements for the European Union ..5. Requirements for EU Countries ..6. European Medicines Agency (EMA) ..7. Requirements for the United States of America ..7. Requirements for Japan ..8. Requirements for 2. CHAPTER 2: OPTIONS & CONSIDERATIONS FOR API MANUFACTURERS TO. HANDLE E-CTD REQUIREMENTS ..9. Evaluation of current submission processes & tools ..9. Boundaries ..10. User Requirement Specification (URS) ..10. Selection of solution ..11. In-house Host system option / Software as a Service (SaaS) ..14. Outsourcing option ..15. Implementation ..18. Document management system (DMS) ..18. Creation of eCTD compliant documents ..19.
APIC_eCTD How to Do Page 6 Requirements for electronic files Electronic files should be in accordance with the Guidance for Industry on Providing Regulatory
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
European Medicines Agency guidance for, European Medicines Agency Guidance for Applicants, Q5C Stability testing of Biotechnological /, Agency, European, Q5C Stability testing of Biotechnological / Biological, ECTD Guidance Document, Guidance, Safety Executive The SACGM, Safety Executive The SACGM Compendium of guidance, November 2011, WHO Special, WHO Special Programme for Research and